Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.
about
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsThe role of Clostridium difficile in the paediatric and neonatal gut - a narrative reviewHealthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, TexasA compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates.Clostridium difficile in the Long-Term Care Facility: Prevention and ManagementCost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.Clostridium Difficile Infection in Acute Care Hospitals: Systematic Review and Best Practices for Prevention.Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence.Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles.Evolving insights into the epidemiology and control of Clostridium difficile in hospitals.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.The drivers of acute and long-term care C. difficile infection rates: a retrospective multilevel cohort study of 251 facilities.Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission.A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection.Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study.An Increase in Healthcare-Associated Clostridium difficile Infection Associated with Use of a Defective Peracetic Acid-Based Surface Disinfectant.Performance of the present-on-admission indicator for Clostridium difficile infection.Clostridium Difficile Infection in the United States: A National Study Assessing Preventive Practices Used and Perceptions of Practice Evidence.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Identification of Clostridium difficile Asymptomatic Carriers in a Tertiary Care Hospital.Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence.Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings.Estimating Local Costs Associated With Clostridium difficile Infection Using Machine Learning and Electronic Medical Records.Attributable Cost of Clostridium difficile Infection in Pediatric Patients.Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)Clostridium-difficile-assoziierte Infektionen im Kindes- und Jugendalter
P2860
Q24187768-4412502A-B107-4B77-A5D8-FDEA8D5C9A75Q26750848-90739624-3A16-42B0-B8F6-50E29F05D7E6Q33945833-38F77E93-29A0-483D-BBC3-3C5A07D71A45Q34470266-D4F7B5AA-881D-4130-9E50-FD375020DB12Q35065783-4EA3E8DD-3B64-45FF-96A1-6DC98322E94CQ36113668-E62B98E9-BE00-4751-80F4-1AAE5A5F109AQ36310096-E4726E75-40F1-4B0E-9D10-41AB4F4741F3Q36635701-6E82B479-D405-438F-AE1A-58E610E5729DQ39200962-B529F2D5-C1DF-4A75-98D4-0CB8FFF85F43Q39315676-44A98AE9-1925-4966-B81B-468DDF05B041Q40125340-7CCD36CB-09FA-4590-84CA-26C247751A3FQ40179998-0C24C3EC-3427-44A7-AD54-7519D267F376Q40209474-1AFD3265-02FE-4FF4-97D0-56E4F353F77CQ40230162-289527BB-1DCB-4C00-8066-7F6F40A5188EQ40347744-461D7D4B-A873-46A1-A195-FAF8FCAF3050Q40443766-42C6707C-A100-4AB8-9EC3-0673A3AE1D31Q41190268-48030A47-E9C4-4E6D-94A2-FEFBC0733B26Q41304019-E3F8CA70-8504-4457-9AE3-7A59DEACA52FQ41996759-E2C46CAC-E3E2-4038-8E95-A584903F25E3Q44593155-1C2A7402-44F0-45A0-897E-ED85DBB806DEQ44607123-CE839DA6-FB83-4221-8581-3F0D015BCBC8Q44868067-A629E309-F8D4-42B2-B049-40C23CB639A8Q45944171-4E96E142-E393-4B66-997B-C4CD06DE2963Q49661909-FBCC4823-BB5A-46E3-BBCF-95EFC5ECABFCQ52707815-E2414496-A2F5-40DA-A18A-7808ED695882Q55103812-22B8640C-D8C4-47E2-AD25-F7037E6A2F4DQ56225357-AB4A4521-77E7-472C-8F5E-9BDA7B728E9DQ58896401-6DDFB5C5-71E5-4EBC-B2BA-A7444C89AE7F
P2860
Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@ast
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@en
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@nl
type
label
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@ast
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@en
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@nl
prefLabel
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@ast
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@en
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@nl
P2093
P2860
P50
P356
P1476
Strategies to prevent Clostrid ...... e care hospitals: 2014 Update.
@en
P2093
David J Weber
Deborah S Yokoe
L Clifford McDonald
Lisa L Maragakis
Philip Carling
Ruth Carrico
Thomas J Sandora
Vivian G Loo
P2860
P304
P356
10.1086/676023
P577
2014-06-01T00:00:00Z